Henan Xixiai Biotechnology

Henan CCAI Biotechnology is a specialized medical technology firm based in Zhengzhou, China, focusing on the development and production of in vitro diagnostic (IVD) solutions. The company primarily develops point-of-care testing (POCT) products, including rapid diagnostic kits for infectious diseases, cardiovascular markers, and inflammatory conditions. Their portfolio includes immunochromatography-based assays and molecular diagnostic tools designed for rapid clinical decision-making in both hospital and laboratory settings. CCAI Biotechnology maintains large-scale manufacturing capabilities compliant with international standards and distributes its products to healthcare providers globally. The company gained significant international visibility for its rapid antigen testing kits during the COVID-19 pandemic.